KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) EPS (Weighted Average and Diluted) (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed EPS (Weighted Average and Diluted) for 9 consecutive years, with -$0.56 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 2700.0% to -$0.56 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.48 through Dec 2025, down 171.64% year-over-year, with the annual reading at -$0.47 for FY2025, 169.12% down from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.56 in Q4 2025 for Elanco Animal Health, down from -$0.07 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.73 in Q3 2024 to a low of -$2.22 in Q3 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.17 across 5 years, with a median of -$0.11 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 176.92% in 2022 and later plummeted 2700.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.22 in 2021, then skyrocketed by 50.0% to -$0.11 in 2022, then plummeted by 163.64% to -$0.29 in 2023, then skyrocketed by 93.1% to -$0.02 in 2024, then tumbled by 2700.0% to -$0.56 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ELAN at -$0.56 in Q4 2025, -$0.07 in Q3 2025, and $0.02 in Q2 2025.